NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. stocks list
    apple-store
  4. WANBURY LIMITED
stock logo

WANBURY LIMITED Share Price

WANBURY

₹211.86+₹10.08 (5.00%) TodayLast updated on 26 Jul, 2024 | 15:27 IST
₹197.03₹211.86
L
Show Current Price
H

  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹526 Crs

Open

₹207.00

Close

₹201.78

Circuit range

₹211.86 - ₹191.69

Day range

₹197.03 - ₹211.86

Year range

₹49.00 - ₹211.86

Volume

3,64,689

Avg. traded

₹207.84

Revenue (12m)

₹576 Crs

WANBURY LIMITEDWanbury Limited is an India-based pharmaceutical company having a presence in active pharmaceutical ingredients (APIs) global market and domestic branded formulations. It is engaged in the business of pharmaceutical and related activities, including research. Its API products include metformin, metformin dc, tramadol, sertraline, diphenhydramine hcl, diphenhydramine citrate, mefenamic acid, paroxetine hemihydrate, promethazine, glucosamine, clopidogrel, levetiracetam and carvedilol phosphate monohydrate. In formulations, the Company has a presence across various therapeutic categories, such as cough and cold solutions, gynecology, orthopedics, nutraceuticals, gastrointestinal, anti-inflammatory and analgesics. The Company is also focused on development of products like ketamine, rivaroxaban, montelukast, sitagliptin and few others to reduce dependency on metformin and sertraline. The Company has USFDA and EUGMP approved facilities at Tanuku, Andra Pradesh, and Patalganga, Maharashtra.

WANBURY LIMITED Key indicators

arrow

52 week high

₹211.86

52 week low

₹49.00

P/E ratio

9.4

P/B ratio

30.91

ROE

--

ROCE

17.68%

Dividend yield

--

Debt/Equity ratio

-7.12

EPS

-3.18

Learn more

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

4.73%

Net profit margin

-2.04%

ROE

0%

ROA

-3.24%

ROCE

17.68%

Learn more

WANBURY LIMITED Shareholder returns

arrow

1 day

+5.00%

1 week

+6.83%

1 month

+25.59%

3 months

+27.19%

1 year

+261.94%

3 years

+125.96%

5 years

+1122.91%

WANBURY LIMITED Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 25 2024
₹190.00
₹201.78
+5.00%
Wed, Jul 24 2024
₹188.10
₹192.18
+1.60%
Tue, Jul 23 2024
₹198.00
₹189.15
-3.55%
Mon, Jul 22 2024
₹186.88
₹196.12
+4.94%
Fri, Jul 19 2024
₹190.70
₹186.88
-1.06%
Thu, Jul 18 2024
₹190.00
₹188.88
-1.78%
Tue, Jul 16 2024
₹202.29
₹192.31
-0.18%
Mon, Jul 15 2024
₹189.90
₹192.66
+5.00%

Shareholding info

arrow

Promoters (39.79%)

Mutual Funds (0%)

Retail and other (59.98%)

Foreign institutions-FII (0.22%)

Other domestic institutions (0%)

Retail and other

Learn more

Frequently asked questions